P
Pliant Therapeutics D
D
PLRX
1.28500
USD
-0.06
(-4.46%)
مغلق
حجم التداول
12,445
الربح لكل سهم
-2
العائد الربحي
-
P/E
-0
حجم السوق
78,881,367
العنوان: Pliant Therapeutics
القطاع: Healthcare
الصناعة: Biotechnology
Pliant Therapeutics Inc is a clinical-stage biopharmaceutical company focused on discovering and developing novel therapies for the treatment of fibrosis and related diseases. Its primary product candidate is bexotegrast (PLN-74809), an oral, small molecule, that the company is developing for the treatment of idiopathic pulmonary fibrosis, or IPF, and primary sclerosing cholangitis.